| Ticker | ABBV |
|---|---|
| ISIN | US00287Y1091 |
| Sector | Atención sanitaria |
| Industria | Drug Manufacturers - General |
| Mercado | NYSE |
| Capitalización | $365.425.816.000 |
| Beta | 0,36 |
| Último dividendo | US$ 6,7400 |
| Sitio web | https://www.abbvie.com |
| CEO | Robert A. Michael |
| Fecha de IPO | 02/01/2013 |
| País | US |
| Dirección | 1 North Waukegan Road, North Chicago, IL, 60064-6400 |
| Volumen | 5.342.169 |
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VEN...
El precio actual de Abbvie (ABBV) es de 206,60, con una variación del -2.23%.
Abbvie opera en el sector Healthcare, industria Drug Manufacturers - General.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones